Design, formulation and evaluation of Azithromycin binary solid dispersions using Kolliphor series for the solubility and in vitro dissolution rate enhancement

Journal of Pharmaceutical Investigation

Volumn 44, Issue 2, 2014, Pages 119-131

  Adeli, Ehsan ^a   Mortazavi, Seyed Alireza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Azithromycin; Dissolution rate; Kolliphor; Solid dispersion; Solubility

Indexed keywords

AZITHROMYCIN; CREMOPHOR; KOLLIPHOR; KOLLIPHOR 237; KOLLIPHOR P 338; KOLLIPHOR P 407; POLOXAMER; UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; DRUG STABILITY; EVAPORATION; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID DISPERSION; X RAY POWDER DIFFRACTION;

EID: 84897097007     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0108-x     Document Type: Article

References (29)

1. Amidon GL, Lennernas H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12: 413-420.
2. Anderson NH, Bauer M, Boussac N, Khan-Malek R, Munden P, Sardaro M (1998) An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J Pharm Biomed Anal 17(4-5): 811-822.
3. Babu GV, Kumar NR, Himasankar K, Seshasayana A, Murthy KV (2003) Nimesulide-modified gum karaya solid mixtures: preparation, characterization and formulation development. Drug Dev Ind Pharm 29: 855-864.
4. Bashiri-Shahroodi A, Nassab PR, Szabó-Révész P, Rajkó R (2008) Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of Meloxicam. Drug Dev Ind Pharm 34: 781-788.
5. Bolourchian N, Mahboobian MM, Dadashzadeh S (2013) The effect of PEG molecular weights on dissolution behavior of Simvastatin in solid dispersions. Iran J Pharm Res 12(Supplement): 11-20.
6. Carson IW, Alexander JP, Hewitt JC, Dundee JW (1972) Clinical studies of induction agents XLI: venous sequelae following the use of the steroid anaesthetic agent, Althesin. Br J Anaesth 44: 1311-1313.
7. Carson IW, Clarke RSJ, Dundee JW (1973) Alterations in response to somatic pain associated with anaesthesia. Br J Pharmacol 47(679): 590-592.
8. Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60(9): 1281-1302.
9. Craig DQ (2002) The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2: 131-144.
10. Deepti DH, Madan AK (2007) Solid dispersion adsorbents for enhancement of dissolution rates of drugs. PDA J Pharm Sci Technol 61(2): 97-101.
11. Ha JM, Kang SY, Park CW, Bin SA, Rhee YS, Seo JW, Kim SH, Chi SC, Park ES (2012) Effect of poloxamer on physicochemical properties of tacrolimus solid dispersion improving water solubility and dissolution rate. J Pharm Investig 42(4): 171-176.
12. Hinkelmann K, Kempthorne O (2008) Design and analysis of experiments I and II, 2nd edn. Wiley, New York.
13. Irving R (1994) Physical basis for poloxamer interactions. Schmolka Company, Grosse Ile. Ann N Y Acad Sci 720: 92-97.
14. Khan KA (1975) The concept of dissolution efficiency. J Pharm Pharmacol 27: 48-49.
15. Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50: 47-60.
16. Moffat AC, Osselton MD, Widdop B (2011) Clarke analysis of drug and poisons, 4th edn. Pharmaceutical Press, London, pp 1561-1562.
17. Mura P, Moyano JR, Gonzalez-Rodrigue ML, Rabasco-Alvarez AM, Cirri M, Maestrelli F (2005) Characterization and dissolution properties of ketoprofeninbinary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev Ind Pharm 31: 425-434.
18. Narasaiah L, Jimidi B, Goli V, Kanakam VB (2011) Enhancement of dissolution rate of atorvastatin calcium using solid dispersions by dropping method. Int J PharmTech Res 3(2): 652-659.
19. Okonogi S, Puttipipatkhachorn S (2006) Dissolution improvement of high drug loaded solid dispersion. AAPS PharmSci Tech 7: E148-E153.
20. Okonogi S, Yonemochi E, Oguchi T, Puttipipatkhachorn S, Yamamoto K (1997) Enhanced dissolution of ursodeoxycholic acid from the solid dispersion. Drug Dev Ind Pharm 23: 1115Y1121.
21. Parmar KR, Shah SR, Sheth NR (2011) Preparation, characterization, and in vitro evaluation of ezetimibe binary solid dispersions with poloxamer 407 and PVP K30. J Pharm Innov 6(2): 107-114.
22. Patel PV, Panchal SS, Mehta TA (2013) Improvement of dissolution rate of tacrolimus by solid dispersion technique. J Pharm Investig 43(1): 45-53.
23. Shim JB, Kim MJ, Kim SJ, Kang SJ, Lee JH, Kim HS, Lee D, Khang G (2012) Dissolution properties of control released solid dispersion of carvedilol with HPMC and Eudragit RS. J Pharm Investig 42(5): 285-291.
24. Sweetman SC (2009) Martindale: the complete drug reference, 36th edn. Pharmaceutical Press, London, p 207.
25. The Indian Pharmacopoeia, Ministry of Health and Family Welfare (2007) Government of India, Azithromycin monograph.
26. USP: United States Pharmacopeia and National Formulary USP 30-NF 25. (2007) The United States, Pharmacopeial Convention, Inc. Rockville, MD, pp 3179-3180.
27. Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D, Löbenberg R (2004) Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm 30: 303-317.
28. van Belle G (2008) Statistical rules of thumb, vol 2. Wiley, Hoboken.
29. Wipo, The World Intellectual Property Organization (2013) Azithromycin: A world best-selling antibiotic-Pliva. http://www. wipo. int/sme/en/case_studies/pliva. htm. Accessed June 2013.